Non-hip fracture | Hip fracture | Hazard ratio (95% confidence interval) | ||||||
---|---|---|---|---|---|---|---|---|
Event | PY | IR | Event | PY | IR | Crude | Adjusted | |
Overall | 35 | 7733 | 0.5 | 59 | 7262 | 0.8 | 1.71 (1.12–2.59)* | 1.62 (1.05–2.49)* |
Sex | ||||||||
Female | 26 | 4702 | 0.6 | 41 | 4802 | 0.9 | 1.53 (0.94–2.51) | 1.52 (0.92–2.53) |
Male | 4 | 3031 | 0.1 | 18 | 2460 | 0.7 | 2.12 (0.95–4.72) | 2.05 (0.90–4.67) |
Age, years | ||||||||
60–69 | 5 | 1006 | 0.5 | 13 | 936 | 1.4 | 2.44 (0.87–6.87) | 2.50 (0.82–7.61) |
70–79 | 19 | 3428 | 0.6 | 25 | 3065 | 0.8 | 1.39 (0.77–2.53) | 1.45 (0.78–2.68) |
80+ | 11 | 3040 | 0.4 | 18 | 3058 | 0.6 | 1.59 (0.75–3.37) | 1.62 (0.76–3.46) |
Comorbidity | ||||||||
HTN | ||||||||
No | 9 | 2580 | 0.3 | 13 | 1904 | 0.7 | 1.75 (0.75–4.11) | 1.71 (0.72–4.06) |
Yes | 26 | 5153 | 0.5 | 46 | 5358 | 0.9 | 1.66 (1.03–2.69)* | 1.63 (0.99–2.66) |
DM | ||||||||
No | 17 | 5230 | 0.3 | 28 | 4357 | 0.6 | 1.88 (1.03–3.45)* | 2.08 (1.12–3.84)* |
Yes | 18 | 2503 | 0.7 | 31 | 2905 | 1.1 | 1.43 (0.80–2.55) | 1.42 (0.77–2.61) |
Hyperlipidemia | ||||||||
No | 14 | 5345 | 0.3 | 29 | 5173 | 0.6 | 2.02 (1.06–3.82)* | 1.84 (0.95–3.54) |
Yes | 21 | 2388 | 0.9 | 30 | 2089 | 1.4 | 1.55 (0.88–2.71) | 1.57 (0.88–2.81) |
CAD | ||||||||
No | 12 | 4042 | 0.3 | 23 | 3663 | 0.6 | 2.00 (0.99–4.02) | 2.09 (1.02–4.25)* |
Yes | 23 | 3691 | 0.6 | 36 | 3599 | 1 | 1.52 (0.90–2.57) | 1.40 (0.82–2.39) |
CVA | ||||||||
No | 18 | 5272 | 0.3 | 25 | 4281 | 0.6 | 1.59 (0.87–2.93) | 1.96 (1.06–3.64)* |
Yes | 17 | 2461 | 0.7 | 34 | 2981 | 1.1 | 1.68 (0.93–3.00) | 1.50 (0.82–2.75) |
Chronic liver disease | ||||||||
No | 21 | 5949 | 0.4 | 46 | 6031 | 0.8 | 2.05 (1.22–3.44)** | 1.98 (1.17–3.35)* |
Yes | 14 | 1784 | 0.8 | 13 | 1231 | 1.1 | 1.23 (0.58–2.63) | 1.08 (0.48–2.41) |